期刊文献+

S(+)-氯胺酮用于临床麻醉镇痛的研究进展 被引量:1

下载PDF
导出
摘要 氯胺酮作为广泛用于临床的麻醉药物,具有不良反应小、起效迅速等特点。S(+)-氯胺酮是氯胺酮的高活性异构体,与N-甲基-D-天冬氨酸等神经元受体有较强亲和力,可通过抑制急性疼痛信号正反馈预防痛觉过敏的发生;其在循环系统中分布时间短,且系统清除率高,用于临床麻醉表现出起效剂量低且复苏时间短的优势;其神经毒性弱于R(-)-氯胺酮及外消旋氯胺酮,用于围手术期麻醉镇痛有一定的心血管保护作用,并在预防术后慢性疼痛方面有积极作用。
出处 《山东医药》 CAS 2022年第19期112-115,共4页 Shandong Medical Journal
基金 广东省医院药学研究基金项目(新晨舒适化医疗专项基金)(2020XC13)。
  • 相关文献

参考文献1

二级参考文献19

  • 1Lumeng CN, Deyoung SM, Bodzin JL, et al. Increased inflammatory properties of adipose tissue macrophages recruited during diet induced obesity. Diabetes, 2007, 56(1 ): 16.
  • 2Dracheva S, Byne W, Chin B, et al. Ionotropic glutamate receptor mRNA expression in the human thalamus: absence of change in schizophrenia. Brain Res, 2008, 1214: 23-34.
  • 3Ushida T, Tani T, Kawasaki M, et al. Peripheral administration of an N -methyl -D -aspartate receptor antagonist (MK -801 ) changes dorsal horn neuronal responses in rats. Neurosci Lett, 1999, 260 (2): 89-92.
  • 4Aley KO, Levine JD. Different peripheral mechanisms mediate enhanced nociception in metabolic/toxic and traumatic painful peripheral neuropathies in the rat. Neuroscience, 2002, 11(42): 389-397.
  • 5Xu L, Mabuchi T, Katano T, et al. Nitric oxide (NO) serves as a retrograde messenger to activate neuronal NO synthase in the spinal cord via NMDA receptors. Nitric Oxide, 2007, 17( 1 ) : 18-24.
  • 6Obata K, Katsura H, Mizushima T, et al. Roles of extracellular signal-regulated protein kinases 5 in spinal microglia and primary sensory neurons for neuropathic pain. J Nenrochem, 2007, 102 (5): 1569-1584.
  • 7Zhang L, Xiao C, Wang JK, et al. Activation of extracellular signal-regulated protein kinases 5 in the spinal cord contributes to the neuropathic pain behaviors induced by CCI in rats. Neurol Res, 200, 31(10): 1037-1043.
  • 8Pedersen LM, Gjerstad J. Spinal cord long-term potentiation is attenuated by the NMDA-2B receptor antagonist Ro 25-6981. Acta Physiol (Oxf), 2008, 192(3 ) : 421-427.
  • 9Qu xx, Cai J, Li M J, et al. Role of the spinal cord NR2B- containing NMDA receptors in the development of neuropathicpain. Exp Neurol, 2009, 215(2): 298-307.
  • 10Nakazato E, Kato A, Watanabe S. Brain but not spinal NR2B receptor is responsible for the anti-allodynic effect of an NR2B subunit-selective antagonist CP-101,606 in a rat chronic constriction injury model. Pharmacology, 2005, 73(1 ) : 8-14.

共引文献1

同被引文献10

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部